title: Influenza virus antigenicity and broadly neutralizing epitopes.
abstract: A vaccine formulation that would be effective against all strains of influenza virus has long been a goal of vaccine developers, but antibodies after infection or vaccination were seen to be strain specific and there was little evidence of cross-reactive antibodies that neutralized across subtypes. Recently a number of broadly neutralizing monoclonal antibodies have been characterized. This review describes the different classes of broadly neutralizing antibodies and discusses the potential of their therapeutic use or for design of immunogens that induce a high proportion of broadly neutralizing antibodies.
authors.affiliation: Department of Biochemistry & Molecular Biology, University of Oklahoma Health Sciences Center, PO Box 26901, Oklahoma City, OK 73126-0901, United States. Electronic address: Gillian-air@ouhsc.edu.
authors.forename: Gillian M
authors.initials: GM
authors.lastname: Air
mesh_terms: D000818:Animals; D057134:Antibodies, Neutralizing / Q000276:immunology*; D000914:Antibodies, Viral / Q000276:immunology*; D000956:Antigens, Viral / Q000276:immunology*; D003429:Cross Reactions; D000939:Epitopes / Q000276:immunology*; D006801:Humans; D064789:Immunity, Heterologous; D009975:Orthomyxoviridae / Q000276:immunology*
chemical_list: D057134:Antibodies, Neutralizing; D000914:Antibodies, Viral; D000956:Antigens, Viral; D000939:Epitopes
references.citation: PLoS One. 2012;7(4):e34415
references.pmid: 22496802
references.citation: J Virol. 2012 Mar;86(6):2978-89
references.pmid: 22238297
references.citation: J Virol. 2011 Oct;85(20):10905-8
references.pmid: 21849447
references.citation: PLoS One. 2014;9(2):e89803
references.pmid: 24587046
references.citation: Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):445-50
references.pmid: 24335589
references.citation: Cell. 1982 Dec;31(2 Pt 1):417-27
references.pmid: 6186384
references.citation: Annu Rev Microbiol. 1954;8:311-32
references.pmid: 13198110
references.citation: Science. 2011 Aug 12;333(6044):850-6
references.pmid: 21798894
references.citation: Science. 2010 Apr 16;328(5976):357-60
references.pmid: 20339031
references.citation: MBio. 2011;2(1):e00345-10
references.pmid: 21304166
references.citation: J Virol. 2014 Jul;88(13):7130-44
references.pmid: 24719430
references.citation: Influenza Other Respir Viruses. 2012 Jul;6(4):245-56
references.pmid: 22085243
references.citation: Nat Commun. 2014;5:3614
references.pmid: 24717798
references.citation: PLoS One. 2008;3(12):e3942
references.pmid: 19079604
references.citation: J Virol. 2011 Nov;85(21):11048-57
references.pmid: 21865387
references.citation: J Virol. 2010 Aug;84(16):8275-86
references.pmid: 20519402
references.citation: Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):17040-5
references.pmid: 23027945
references.citation: J Infect Dis. 2015 Apr 1;211(7):1038-44
references.pmid: 25281755
references.citation: PLoS Pathog. 2013;9(10):e1003657
references.pmid: 24130481
references.citation: J Virol. 2013 Mar;87(6):3571-7
references.pmid: 23269809
references.citation: Immunology. 2006 Sep;119(1):1-7
references.pmid: 16925526
references.citation: J Virol. 2014 Jun;88(12):7083-92
references.pmid: 24719426
references.citation: Proc Natl Acad Sci U S A. 2013 Jan 2;110(1):264-9
references.pmid: 23175789
references.citation: Antiviral Res. 2013 Nov;100(2):567-74
references.pmid: 24091204
references.citation: Proc Natl Acad Sci U S A. 2014 Sep 9;111(36):13133-8
references.pmid: 25157133
references.citation: Biochem Biophys Res Commun. 2013 Nov 8;441(1):226-9
references.pmid: 24140051
references.citation: Antiviral Res. 2014 Jul;107:76-83
references.pmid: 24797696
references.citation: Biochem Biophys Res Commun. 2009 Sep 11;387(1):180-5
references.pmid: 19580789
references.citation: Science. 2012 Sep 14;337(6100):1343-8
references.pmid: 22878502
references.citation: Virology. 2012 Aug 15;430(1):63-72
references.pmid: 22595444
references.citation: J Virol. 1993 May;67(5):2552-8
references.pmid: 7682624
references.citation: Nature. 1981 Jan 29;289(5796):373-8
references.pmid: 6162101
references.citation: Virology. 1980 Jul 15;104(1):139-48
references.pmid: 6156537
references.citation: PLoS One. 2012;7(7):e41895
references.pmid: 22848649
references.citation: Nat Struct Mol Biol. 2013 Mar;20(3):363-70
references.pmid: 23396351
references.citation: MBio. 2010 May 18;1(1):null
references.pmid: 20689752
references.citation: Science. 2009 Apr 10;324(5924):246-51
references.pmid: 19251591
references.citation: PLoS One. 2012;7(5):e38126
references.pmid: 22662275
references.citation: J Virol. 2014 Nov;88(22):13260-8
references.pmid: 25210189
references.citation: Cell. 1990 May 18;61(4):553-6
references.pmid: 1693095
references.citation: J Gen Virol. 2013 Aug;94(Pt 8):1712-22
references.pmid: 23636824
references.citation: Cell Host Microbe. 2013 Jul 17;14(1):93-103
references.pmid: 23870317
references.citation: Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):14216-21
references.pmid: 21825125
references.citation: Nature. 2012 Sep 27;489(7417):526-32
references.pmid: 22982990
references.citation: Nat Struct Mol Biol. 2009 Mar;16(3):265-73
references.pmid: 19234466
references.citation: J Virol. 2013 Dec;87(23):12619-35
references.pmid: 24049169
references.citation: Virol J. 2013;10:148
references.pmid: 23672256
references.citation: Proc Natl Acad Sci U S A. 2014 Jun 24;111(25):E2514-23
references.pmid: 24927560
references.citation: Curr Top Microbiol Immunol. 2015;386:323-41
references.pmid: 25037260
references.citation: Virol J. 2013;10:227
references.pmid: 23834899
references.citation: PLoS Pathog. 2012;8(12):e1003067
references.pmid: 23236279
references.citation: J Virol. 2013 Aug;87(16):9290-300
references.pmid: 23785204
references.citation: Virology. 2013 Jan 20;435(2):320-8
references.pmid: 23084424
references.citation: J Virol. 2013 Jun;87(12):7149-54
references.pmid: 23552413
references.citation: J Virol. 2013 Feb;87(4):2215-25
references.pmid: 23221567
references.citation: Science. 2011 Aug 12;333(6044):843-50
references.pmid: 21737702